By Femtech Insider Biotech, Cancer, Endometriosis, News, Pharma January 11, 2024 ShareTwitterFacebookPinterest-circled Pearsanta Acquires MDNA’s Mitomic Platform for Endometriosis and Ovarian Cancer Detection for $25M
By Femtech Insider Fertility, News, Pharma, Reproductive Health January 11, 2024 ShareTwitterFacebookPinterest-circled Marius Pharmaceuticals Initiates Study on Oral Testosterone Therapy and Male Fertility
By Femtech Insider News, Reproductive Health January 11, 2024 ShareTwitterFacebookPinterest-circled Health Canada Approves Natural Cycles App as Birth Control
By Femtech Insider News, Newsletter January 11, 2024 ShareTwitterFacebookPinterest-circled What’s New in Femtech This Week? (Jan 10, 2024)
By Femtech Insider Fertility, News, Reproductive Health January 10, 2024 ShareTwitterFacebookPinterest-circled ReproTech Introduces Cryo-Logix to Streamline Cryostorage for IVF Clinics
By Femtech Insider Biotech, Chronic Conditions, Menstrual Health, News January 9, 2024 ShareTwitterFacebookPinterest-circled Qvin’s Q-Pad Makes History with First FDA Approval for Menstrual Blood Health Testing
By Femtech Insider Consumer Health, Gynecological Health, News January 9, 2024 ShareTwitterFacebookPinterest-circled Vivoo Unveils New At-Home UTI Test at CES 2024
By Femtech Insider Health Equity, Investment, News January 9, 2024 ShareTwitterFacebookPinterest-circled Health In Her HUE Secures $3M in Seed Funding to Expand Services for Women of Color
